Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to ...

The biotech automation company released artificial intelligence software controlling robotic systems in pharmaceutical and biologics production facilities.

As these industries of the future take center stage, they offer a clear opportunity to build a new era of Sino-European partnership founded on shared innovation and mutual benefit. The future is ...

Through Bota's proprietary Biological Protocol Language, SAION AI converts experimental designs into standardized instructions that directly drive laboratory hardware, feeding real-world data back ...